Showing results (591-600 of 602) with videos related to

Sort By:
Pageof 61
Frontiers in Immunology|June 11, 2026
Preclinical study on an adsorbed acellular diphtheria- tetanus-pertussis (reduced-dose) combined vaccine: evaluation of reproductive safety and immunogenicityHan Chu, Wenlu Kong, Qin Gu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 28, 2016
[FLT3-ITD Mutation in Newly Diagnosed Patients with Acute Promyelocytic Leukemia]Ben-Fa Gong, Ying Wang, Dong Lin, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|May 8, 2015
[Efficacy Analysis of MAC Regimen as Salvage Treatment Protocol for Acute Myeloid Leukemia Patients Older Than 55 Years]Xing-Li Zhao, Shu-Ning Wei, Kai-Qi Liu, et al.
Vaccine|January 30, 2026
Preliminary safety evaluation of a diphtheria, tetanus, acellular component pertussis, Sabin inactivated poliovirus and Haemophilus influenzae type b combination vaccine (DTacP-sIPV/Hib)Lukui Cai, Yixian Fu, Jingyan Li, et al.
The Journal of Clinical Investigation|April 8, 2021
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentationHanchen Xu, Kevin Van der Jeught, Zhuolong Zhou, et al.
Acta Pharmacologica Sinica|July 30, 2013
Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivoJian Shi, Bei Cao, Wei-Bin Zha, et al.
Vaccines|January 28, 2026
Preclinical Study on Sabin Strain-Based DTaP-sIPV/Hib Pentavalent Vaccine: Evaluation of Repeated-Dose Toxicity and ImmunogenicityTing Zhao, Han Chu, Yan Ma, et al.
Vaccines|October 28, 2025
Preclinical Immunogenicity Evaluation of a DTacP-sIPV/Hib Combination Vaccine in Rodent Models Under Varying Formulations and Immunization SchedulesYixian Fu, Wei Huang, Lukui Cai, et al.
Nature Communications|October 26, 2022
Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetesXiaoxiao Yuan, Ruirui Wang, Bing Han, et al.
Chinese Journal of Integrative Medicine|December 10, 2016
Effect of Shuanghu Qinggan Granule () and Yigan Yiqi Jieyu Granule () plus lamivudine on chronic hepatitis B patients: A randomized double-blind placebo-controlled trialYong-An Ye, De-Lu Tian, Jian Jiang, et al.
Pageof 61